• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2017 Fiscal Year Final Research Report

Development of cytokine gene therapy with high therapeutic index by systemic regulation of transgene expression and biological response.

Research Project

  • PDF
Project/Area Number 15H04638
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Physical pharmacy
Research InstitutionKyoto University

Principal Investigator

Takakura Yoshinobu  京都大学, 薬学研究科, 教授 (30171432)

Co-Investigator(Kenkyū-buntansha) 高橋 有己  京都大学, 薬学研究科, 准教授 (00547870)
Project Period (FY) 2015-04-01 – 2018-03-31
Keywords遺伝子治療 / サイトカイン / プラスミドDNA
Outline of Final Research Achievements

Interferon-β(IFNβ) is a cytokine with pleiotropic and potent bioactivity. In this study, effective IFNβ gene therapy was developed. First, a plasmid vector named as pMX- IFNβ, which is driven by Mx promoter, was developed to achieve sustained IFNβ transgene expression. Sustained IFNβ expression from pMX- IFNβ was effective in treating cancer and multiple sclerosis (MS) in model mice. Moreover, by designing a fusion protein of galectin-9 (gal9) and IFNβ named as IFNβ-gal9, it was succeeded in improving therapeutic effect of IFNβ on MS and reducing adverse effect of IFNβ. In conclusion, IFN gene therapy with high therapeutic index was successfully developed.

Free Research Field

生物薬剤学

URL: 

Published: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi